Mizolastine
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | By mouth (tablets) |
| ATC code | R06AX25 (WHO) |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
108612-45-9 |
| PubChem (CID) | 65906 |
| ChemSpider |
59315 |
| UNII |
244O1F90NA |
| KEGG |
D01117 |
| ChEMBL |
CHEMBL94454 |
| Chemical and physical data | |
| Formula | C24H25FN6O |
| Molar mass | 432.493 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Mizolastine (Mizollen) is a once-daily, non-sedating antihistamine. It blocks H1 receptors and is commonly fast-acting. It does not prevent the actual release of histamine from mast cells, just prevents it binding to receptors. Side effects can include dry mouth and throat.[1]
References
- ↑ "MIZOLASTINE: British National Formulary". Retrieved 2010-02-01.
This article is issued from Wikipedia - version of the 10/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
